Search filters

List of works by Sarah Gilbert

4-1BBL enhances CD8+ T cell responses induced by vectored vaccines in mice but fails to improve immunogenicity in rhesus macaques

scientific article

A DNA prime-modified vaccinia virus ankara boost vaccine encoding thrombospondin-related adhesion protein but not circumsporozoite protein partially protects healthy malaria-naive adults against Plasmodium falciparum sporozoite challenge.

scientific article

A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA

scientific article

A Multi-Filovirus Vaccine Candidate: Co-Expression of Ebola, Sudan, and Marburg Antigens in a Single Vector

scientific article published on 21 May 2020

A Plasmodium falciparum candidate vaccine based on a six-antigen polyprotein encoded by recombinant poxviruses

scholarly article

A T cell-inducing influenza vaccine for the elderly: safety and immunogenicity of MVA-NP+M1 in adults aged over 50 years

scientific article

A clinical trial of prime-boost immunisation with the candidate malaria vaccines RTS,S/AS02A and MVA-CS.

scientific article

A human Phase I/IIa malaria challenge trial of a polyprotein malaria vaccine

scientific article

A multi-antigenic adenoviral-vectored vaccine improves BCG-induced protection of goats against pulmonary tuberculosis infection and prevents disease progression

scientific article

A naturally protective epitope of limited variability as an influenza vaccine target

scientific article published in Nature Communications

A novel chimpanzee adenovirus vector with low human seroprevalence: improved systems for vector derivation and comparative immunogenicity

scientific article (publication date: 2012)

A novel multi-antigen virally vectored vaccine against Mycobacterium avium subspecies paratuberculosis

scientific article

A phase 2b randomised trial of the candidate malaria vaccines FP9 ME-TRAP and MVA ME-TRAP among children in Kenya

scientific article

A phase IIb study to determine the safety and efficacy of candidate INfluenza Vaccine MVA-NP+M1 in combination with licensed Ina CTivated infl Uenza vaccine in adult S aged 65 years and above (INVICTUS): a study protocol

scientific article published on 23 May 2019

A phase Ia study to assess the safety and immunogenicity of new malaria vaccine candidates ChAd63 CS administered alone and with MVA CS.

scientific article

A potent neutralizing epitope of limited variability in the head domain of haemagglutinin as a novel influenza vaccine target

A prime-boost immunisation regimen using DNA followed by recombinant modified vaccinia virus Ankara induces strong cellular immune responses against the Plasmodium falciparum TRAP antigen in chimpanzees

scientific article

A protein particle vaccine containing multiple malaria epitopes

scientific article published on November 1, 1997

A randomised, double-blind, controlled vaccine efficacy trial of DNA/MVA ME-TRAP against malaria infection in Gambian adults

scientific article

A single dose of ChAdOx1 MERS provides broad protective immunity against a variety of MERS-CoV strains

scientific article published on 14 April 2020

A single dose of ChAdOx1 MERS provides protective immunity in rhesus macaques

scientific article published on 01 May 2020

A single immunization with MVA expressing GnGc glycoproteins promotes epitope-specific CD8+-T cell activation and protects immune-competent mice against a lethal RVFV infection

scientific article published on 11 July 2013

A single-dose ChAdOx1-vectored vaccine provides complete protection against Nipah Bangladesh and Malaysia in Syrian golden hamsters.

scientific article published on 6 June 2019

Achieving global equity for COVID-19 vaccines: Stronger international partnerships and greater advocacy and solidarity are needed

scientific article published on 13 September 2021

Activation of cross-reactive mucosal T and B cell responses in human nasopharynx-associated lymphoid tissue in vitro by Modified Vaccinia Ankara-vectored influenza vaccines.

scientific article

Adenoviral vectors as novel vaccines for influenza.

scientific article

Adenovirus-vectored Ebola vaccines

scientific article published on 18 August 2015

Advances in the development of universal influenza vaccines

scientific article published on September 24, 2012

Altered peptide ligands narrow the repertoire of cellular immune responses by interfering with T-cell priming

scientific article

Alternating vector immunizations encoding pre-erythrocytic malaria antigens enhance memory responses in a malaria endemic area

scientific article published in August 2006

An Ad/MVA vectored antigen induces schizont-specific CD8 central memory T cells and confers partial protection against a lethal challenge

scientific article published on 11 September 2018

Anti-CD25 antibody enhancement of vaccine-induced immunogenicity: increased durable cellular immunity with reduced immunodominance

scientific article published in December 2005

Antibody evasion by the P.1 strain of SARS-CoV-2

scientific article

Assessment of novel vaccination regimens using viral vectored liver stage malaria vaccines encoding ME-TRAP.

scientific article published on 21 February 2018

Association of malaria parasite population structure, HLA, and immunological antagonism.

scientific article published in February 1998

Boosting with poxviruses enhances Mycobacterium bovis BCG efficacy against tuberculosis in guinea pigs

scientific article published on June 2005

CD4+ T Follicular Helper Cells in Human Tonsils and Blood Are Clonally Convergent but Divergent from Non-Tfh CD4+ Cells

scientific article published on 01 January 2020

Calculation of liver-to-blood inocula, parasite growth rates, and preerythrocytic vaccine efficacy, from serial quantitative polymerase chain reaction studies of volunteers challenged with malaria sporozoites

scientific article

Cellular immune responses induced in cattle by heterologous prime-boost vaccination using recombinant viruses and bacille Calmette-Guérin

scientific article published on July 2004

ChAd63-MVA-vectored blood-stage malaria vaccines targeting MSP1 and AMA1: assessment of efficacy against mosquito bite challenge in humans

scientific article

ChAdOx1 and MVA based vaccine candidates against MERS-CoV elicit neutralising antibodies and cellular immune responses in mice

scientific article published on June 2017

ChAdOx1 nCoV-19 (AZD1222) protects Syrian hamsters against SARS-CoV-2 B.1.351 and B.1.1.7

scientific article

ChAdOx1 nCoV-19 (AZD1222) protects Syrian hamsters against SARS-CoV-2 B.1.351 and B.1.1.7.

scientific article published on 07 October 2021

ChAdOx1 nCoV-19 vaccination prevents SARS-CoV-2 pneumonia in rhesus macaques

scientific article published on 14 May 2020

ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques

scientific article published on 30 July 2020

Characterization of the fine specificity of bovine CD8 T-cell responses to defined antigens from the protozoan parasite Theileria parva

scientific article

Chimpanzee Adenovirus Vaccine Provides Multispecies Protection against Rift Valley Fever

scientific article published on 5 February 2016

Chimpanzee adenoviral vectors as vaccines for outbreak pathogens

scientific article published on 30 October 2017

Clinical assessment of a novel recombinant simian adenovirus ChAdOx1 as a vectored vaccine expressing conserved Influenza A antigens

scientific article published on 30 December 2013

Clinical assessment of a recombinant simian adenovirus ChAd63: a potent new vaccine vector

scientific article published on 24 January 2012

Clinical development of Modified Vaccinia virus Ankara vaccines

scientific article published on March 21, 2013

Coadministration of seasonal influenza vaccine and MVA-NP+M1 simultaneously achieves potent humoral and cell-mediated responses

scientific article published on 08 July 2013

Combining liver- and blood-stage malaria viral-vectored vaccines: investigating mechanisms of CD8+ T cell interference

scientific article published on 29 August 2011

Comparison of modeling methods to determine liver-to-blood inocula and parasite multiplication rates during controlled human malaria infection

scientific article published on 09 April 2013

Comparison of numerous delivery systems for the induction of cytotoxic T lymphocytes by immunization

scientific article published in August 1996

Competition Between CTL Narrows the Immune Response Induced by Prime-Boost Vaccination Protocols

scientific article published in May 2002

Correction: Evidence of Blood Stage Efficacy with a Virosomal Malaria Vaccine in a Phase IIa Clinical Trial.

scientific article published on 26 February 2011

Correction: MVA.85A Boosting of BCG and an Attenuated, Deficient Vaccine Both Show Protective Efficacy Against Tuberculosis in Rhesus Macaques

Correction: Recombination-Mediated Genetic Engineering of a Bacterial Artificial Chromosome Clone of Modified Vaccinia virus Ankara (MVA).

scientific article

Correction: Single-dose immunogenicity and protective efficacy of simian adenoviral vectors against Plasmodium berghei

Corrections. Emergency Ebola response: a new approach to the rapid design and development of vaccines against emerging diseases

scientific article published on 20 January 2015

Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection

scientific article published in November 2021

Corrigendum to "Heterologous Two-dose Vaccination with Simian Adenovirus and Poxvirus Vectors Elicits Long-lasting Cellular Immunity to Influenza Virus A in Healthy Adults" [EBioMedicine 29 (2018) 146-154].

scientific article published on 5 May 2018

Cytotoxic T-lymphocyte epitopes for HLA-B53 and other HLA types in the malaria vaccine candidate liver-stage antigen 3

scientific article

DNA multi-CTL epitope vaccines for HIV and Plasmodium falciparum: immunogenicity in mice.

scientific article published in February 1998

DNA-based vaccines for malaria: a heterologous prime-boost immunisation strategy

scientific article published on January 1, 2000

Deletion of Fifteen Open Reading Frames from Modified Vaccinia Virus Ankara Fails to Improve Immunogenicity

scientific article published on 8 June 2015

Dendritic cells infected by recombinant modified vaccinia virus Ankara retain immunogenicity in vivo despite in vitro dysfunction

scientific article published in October 2004

Detection of Vaccine-Induced Antibodies to Ebola Virus in Oral Fluid

scientific article published on January 2016

Determining the validity of hospital laboratory reference intervals for healthy young adults participating in early clinical trials of candidate vaccines

scientific article published on 03 June 2013

Development and use of Lentiviral Vectors Pseudotyped with Influenza B Haemagglutinins: application to vaccine immunogenicity, mAb potency and sero-surveillance studies

Development of an objective gene expression panel as an alternative to self-reported symptom scores in human influenza challenge trials

scientific article published on 08 June 2017

Differential effects of viral vectors on migratory afferent lymph dendritic cells in vitro predict enhanced immunogenicity in vivo.

scientific article

Differential immunogenicity between HAdV-5 and chimpanzee adenovirus vector ChAdOx1 is independent of fiber and penton RGD loop sequences in mice

scientific article

Differential immunogenicity of various heterologous prime-boost vaccine regimens using DNA and viral vectors in healthy volunteers

scientific article published on January 2005

Disruption of the Saccharomyces cerevisiae YAP3 gene reduces the proteolytic degradation of secreted recombinant human albumin

scientific article published in January 1998

Distinguishing malaria and influenza: early clinical features in controlled human experimental infection studies

scientific article

Does melanoma begin in a melanocyte stem cell?

scientific article published on 18 December 2012

Dry-coated live viral vector vaccines delivered by nanopatch microprojections retain long-term thermostability and induce transgene-specific T cell responses in mice

scientific article published on 09 July 2013

Dual neonate vaccine platform against HIV-1 and M. tuberculosis

scientific article

Durable human memory T cells quantifiable by cultured enzyme-linked immunospot assays are induced by heterologous prime boost immunization and correlate with protection against malaria

scientific article published on November 2005

Early gamma interferon and interleukin-2 responses to vaccination predict the late resting memory in malaria-naïve and malaria-exposed individuals

scientific article

Effective induction of high-titer antibodies by viral vector vaccines

scientific article published on 27 July 2008

Efficacy assessment of an MVA vectored Rift Valley Fever vaccine in lambs

scientific article published on 14 June 2014

Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial

scientific article

Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant

scholarly article by Andrew Pollard published in 2021

Emergency Ebola response: a new approach to the rapid design and development of vaccines against emerging diseases

scientific article

Enhanced CD8 T cell immunogenicity and protective efficacy in a mouse malaria model using a recombinant adenoviral vaccine in heterologous prime-boost immunisation regimes

scientific article published in January 2002

Enhanced CD8+ T cell immune responses and protection elicited against Plasmodium berghei malaria by prime boost immunization regimens using a novel attenuated fowlpox virus

scientific article published in March 2004

Enhanced T cell-mediated protection against malaria in human challenges by using the recombinant poxviruses FP9 and modified vaccinia virus Ankara

scientific article

Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans

scientific article published on 25 May 2003

Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara

scientific article published in April 1998

Enhanced immunogenicity of CD4(+) t-cell responses and protective efficacy of a DNA-modified vaccinia virus Ankara prime-boost vaccination regimen for murine tuberculosis

scientific article

Enhancement of MHC class I-restricted peptide-specific T cell induction by a DNA prime/MVA boost vaccination regime

scientific article published on 01 March 1998

Enhancing blood-stage malaria subunit vaccine immunogenicity in rhesus macaques by combining adenovirus, poxvirus, and protein-in-adjuvant vaccines

scientific article published on 22 November 2010

Enhancing cellular immunogenicity of MVA-vectored vaccines by utilizing the F11L endogenous promoter

scientific article published on 23 November 2015

Enhancing protective immunity to malaria with a highly immunogenic virus-like particle vaccine

scientific article

Evaluation of the efficacy of ChAd63-MVA vectored vaccines expressing circumsporozoite protein and ME-TRAP against controlled human malaria infection in malaria-naive individuals

scientific article

Evaluation of the immunogenicity of prime-boost vaccination with the replication-deficient viral vectored COVID-19 vaccine candidate ChAdOx1 nCoV-19

scientific article published on 27 July 2020

Evidence of blood stage efficacy with a virosomal malaria vaccine in a phase IIa clinical trial

scientific article

Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine induced sera

scientific article published in February 2021

Examination of influenza specific T cell responses after influenza virus challenge in individuals vaccinated with MVA-NP+M1 vaccine

scientific article

Expression and cellular immunogenicity of a transgenic antigen driven by endogenous poxviral early promoters at their authentic loci in MVA

scientific article (publication date: 2012)

Expression of tak1 and tram induces synergistic pro-inflammatory signalling and adjuvants DNA vaccines

scientific article

Extended follow-up following a phase 2b randomized trial of the candidate malaria vaccines FP9 ME-TRAP and MVA ME-TRAP among children in Kenya

scientific article

External quality assurance of malaria nucleic acid testing for clinical trials and eradication surveillance

scientific article (publication date: 2014)

Fusion of the Mycobacterium tuberculosis antigen 85A to an oligomerization domain enhances its immunogenicity in both mice and non-human primates

scientific article (publication date: 2012)

Gene gun intradermal DNA immunization followed by boosting with modified vaccinia virus Ankara: enhanced CD8+ T cell immunogenicity and protective efficacy in the influenza and malaria models

scientific article published in November 1999

Generation and Production of Modified Vaccinia Virus Ankara (MVA) as a Vaccine Vector

scientific article published on January 2017

Genetic analysis of host-parasite coevolution in human malaria

scientific article

Heterologous Combination of ChAdOx1 and MVA Vectors Expressing Protein NS1 as Vaccination Strategy to Induce Durable and Cross-Protective CD8+ T Cell Immunity to Bluetongue Virus

scientific article published on 29 June 2020

Heterologous Two-Dose Vaccination with Simian Adenovirus and Poxvirus Vectors Elicits Long-Lasting Cellular Immunity to Influenza Virus A in Healthy Adults.

scientific article

Heterologous priming-boosting immunization of cattle with Mycobacterium tuberculosis 85A induces antigen-specific T-cell responses

scientific article

How many paediatric referrals to an allergist could be managed by a general practitioner with special interest?

scientific article published on 17 November 2015

Human leukocyte antigens and natural selection by malaria

scientific article published on 01 November 1994

Humoral Immunogenicity and Efficacy of a Single Dose of ChAdOx1 MERS Vaccine Candidate in Dromedary Camels

scientific article published on 08 November 2019

Immunity against heterosubtypic influenza virus induced by adenovirus and MVA expressing nucleoprotein and matrix protein-1.

scientific article published on January 2013

Immunity, safety and protection of an Adenovirus 5 prime--Modified Vaccinia virus Ankara boost subunit vaccine against Mycobacterium avium subspecies paratuberculosis infection in calves

scientific article

Immunogenicities of intravenous and intramuscular administrations of modified vaccinia virus Ankara-based multi-CTL epitope vaccine for human immunodeficiency virus type 1 in mice

scientific article

Immunogenicity and efficacy of a chimpanzee adenovirus-vectored Rift Valley fever vaccine in mice

scientific article

Immunogenicity and protective efficacy of mycobacterial DNA vaccines incorporating plasmid-encoded cytokines against Mycobacterium bovis

Immunogenicity of the candidate malaria vaccines FP9 and modified vaccinia virus Ankara encoding the pre-erythrocytic antigen ME-TRAP in 1-6 year old children in a malaria endemic area

scientific article published on 31 March 2006

Immunological and pathological outcomes of SARS-CoV-2 challenge following formalin-inactivated vaccine in ferrets and rhesus macaques

scientific article published on 10 September 2021

Impact on malaria parasite multiplication rates in infected volunteers of the protein-in-adjuvant vaccine AMA1-C1/Alhydrogel+CPG 7909.

scientific article

Improved adjuvanting of seasonal influenza vaccines: preclinical studies of MVA-NP+M1 coadministration with inactivated influenza vaccine

scientific article

Improved method for distinguishing the human source of mosquito blood meals between close family members

scientific article published in September 2000

Incidental diagnosis in healthy clinical trial subjects

scientific article

Increase in copy number of an integrated vector during continuous culture of Hansenula polymorpha expressing functional human haemoglobin

article

Increased sample volume and use of quantitative reverse-transcription PCR can improve prediction of liver-to-blood inoculum size in controlled human malaria infection studies

scientific article

Induction of CD8+ T cells using heterologous prime-boost immunisation strategies

scientific article

Infection- or AZD1222 vaccine-mediated immunity reduces SARS-CoV-2 transmission but increases Omicron competitiveness in hamsters

scientific article published on 18 October 2023

Influenza vaccines and immunopathology

scientific article published on August 1, 2012

Influenza vaccines: Where do we stand? Where do we go?: A bumpy but steady road upwards

scientific article published on 5 September 2015

Innate immune responses to human malaria: heterogeneous cytokine responses to blood-stage Plasmodium falciparum correlate with parasitological and clinical outcomes

scientific article published on October 2006

Intranasal ChAdOx1 nCoV-19/AZD1222 vaccination reduces viral shedding after SARS-CoV-2 D614G challenge in preclinical models

scientific article published on 18 August 2021

Inverse associations of human leukocyte antigen and malaria parasite types in two West African populations

scientific article published on February 2005

Investigation of IRES Insertion into the Genome of Recombinant MVA as a Translation Enhancer in the Context of Transcript Decapping

scientific article published on 26 May 2015

Learning in the Wild: Coding Reddit for Learning and Practice

Long-term thermostabilization of live poxviral and adenoviral vaccine vectors at supraphysiological temperatures in carbohydrate glass

scientific article published in February 2010

Low-level malaria infections detected by a sensitive polymerase chain reaction assay and use of this technique in the evaluation of malaria vaccines in an endemic area

scientific article published on March 2007

MERS-CoV Spike Glycoprotein (GP) – ELISA Jenner Clinical SOP Template v1

scientific article published on 22 May 2020

MVA-NP+M1 vaccine activates mucosal M1-specific T cell immunity and tissue-resident memory T cells in human nasopharynx-associated lymphoid tissue

scientific article published on 19 November 2019

MVA.85A boosting of BCG and an attenuated, phoP deficient M. tuberculosis vaccine both show protective efficacy against tuberculosis in rhesus macaques

scientific article

Making the Move: A Mixed Research Integrative Review

scientific article published on 26 August 2015

Memory CD8 T cell responses exceeding a large but definable threshold provide long-term immunity to malaria

scholarly article

Migratory sub-populations of afferent lymphatic dendritic cells differ in their interactions with Mycobacterium bovis Bacille Calmette Guerin.

scientific article

Modification of Adenovirus vaccine vector-induced immune responses by expression of a signalling molecule

scientific article published on 31 March 2020

Modification of Antigen Impacts on Memory Quality after Adenovirus Vaccination

scientific article published on 4 March 2016

Modified vaccinia virus Ankara-based vaccine vectors induce apoptosis in dendritic cells draining from the skin via both the extrinsic and intrinsic caspase pathways, preventing efficient antigen presentation.

scientific article

New Candidate Vaccines against Blood-Stage Plasmodium falciparum Malaria: Prime-Boost Immunization Regimens Incorporating Human and Simian Adenoviral Vectors and Poxviral Vectors Expressing an Optimized Antigen Based on Merozoite Surface Protein 1

scholarly article by Anna L. Goodman et al published 19 April 2011 in Infection and Immunity

New candidate vaccines against blood-stage Plasmodium falciparum malaria: prime-boost immunization regimens incorporating human and simian adenoviral vectors and poxviral vectors expressing an optimized antigen based on merozoite surface protein 1

scientific article

No easy route to a pandemic influenza vaccine

scientific article published on January 29, 2013

No one is safe until we are all safe

scientific article published on 6 October 2021

Novel Bivalent Viral-Vectored Vaccines Induce Potent Humoral and Cellular Immune Responses Conferring Protection against Stringent Influenza A Virus Challenge.

scientific article

Novel protein and poxvirus-based vaccine combinations for simultaneous induction of humoral and cell-mediated immunity

scientific article published in July 2005

Phase 1 evaluation of 3 highly immunogenic prime-boost regimens, including a 12-month reboosting vaccination, for malaria vaccination in Gambian men.

scientific article published on 24 May 2004

Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses

scientific article

Phase Ia clinical evaluation of the Plasmodium falciparum blood-stage antigen MSP1 in ChAd63 and MVA vaccine vectors

scientific article published on 23 August 2011

Phase Ia clinical evaluation of the safety and immunogenicity of the Plasmodium falciparum blood-stage antigen AMA1 in ChAd63 and MVA vaccine vectors

scientific article (publication date: 2012)

Poly(lactic acid) and poly(lactic-co-glycolic acid) particles as versatile carrier platforms for vaccine delivery

scientific article

Potent CD8+ T-cell immunogenicity in humans of a novel heterosubtypic influenza A vaccine, MVA-NP+M1.

scientific article

Poxvirus vectors

scientific article

Preliminary assessment of the efficacy of a T-cell-based influenza vaccine, MVA-NP+M1, in humans

scientific article

Prevalence of serum neutralizing antibodies against chimpanzee adenovirus 63 and human adenovirus 5 in Kenyan children, in the context of vaccine vector efficacy

scientific article published on 16 April 2009

Preventing spontaneous genetic rearrangements in the transgene cassettes of adenovirus vectors

scientific article

Prime-Boost Immunization with Adenoviral and Modified Vaccinia Virus Ankara Vectors Enhances the Durability and Polyfunctionality of Protective Malaria CD8+T-Cell Responses

article

Prime-boost immunisation against tropical theileriosis with two parasite surface antigens: evidence for protection and antigen synergy

scientific article published on 14 July 2011

Prime-boost immunization with adenoviral and modified vaccinia virus Ankara vectors enhances the durability and polyfunctionality of protective malaria CD8+ T-cell responses

scientific article

Prime-boost vectored malaria vaccines: progress and prospects

scientific article published on 18 January 2010

Progression of Plasmodium berghei through Anopheles stephensi is density-dependent

scientific article

Protection from Plasmodium berghei infection by priming and boosting T cells to a single class I-restricted epitope with recombinant carriers suitable for human use.

scientific article

Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation

scientific article published on January 2013

Protective efficacy of a novel simian adenovirus vaccine against lethal MERS-CoV challenge in a transgenic human DPP4 mouse model

scientific article published on 16 October 2017

Protein particle vaccines against malaria

scientific article published in August 1997

Quantitative real-time polymerase chain reaction for malaria diagnosis and its use in malaria vaccine clinical trials.

scientific article published in July 2005

Rapid development of vaccines against emerging pathogens: The replication-deficient simian adenovirus platform technology

scientific article published on 30 May 2017

Rapid generation of markerless recombinant MVA vaccines by en passant recombineering of a self-excising bacterial artificial chromosome

scientific article published on 24 April 2010

Rational Zika vaccine design via the modulation of antigen membrane anchors in chimpanzee adenoviral vectors.

scientific article

Recombinant Viral Vaccines Expressing Merozoite Surface Protein-1 Induce Antibody- and T Cell-Mediated Multistage Protection against Malaria

scientific article published on 16 March 2011

Recombinant modified vaccinia Ankara primes functionally activated CTL specific for a melanoma tumor antigen epitope in melanoma patients with a high risk of disease recurrence

scientific article published in January 2005

Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans

scientific article

Recombinant modified vaccinia virus Ankara-based malaria vaccines

scientific article published on 29 October 2015

Recombinant viral vaccines expressing merozoite surface protein-1 induce antibody- and T cell-mediated multistage protection against malaria

scientific article published on January 2009

Recombinant viral-vectored vaccines expressing Plasmodium chabaudi AS apical membrane antigen 1: mechanisms of vaccine-induced blood-stage protection

scientific article

Recombination-mediated genetic engineering of a bacterial artificial chromosome clone of modified vaccinia virus Ankara (MVA).

scientific article

Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera

scientific article

Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum

Safety and High Level Efficacy of the Combination Malaria Vaccine Regimen of RTS,S/AS01B With Chimpanzee Adenovirus 63 and Modified Vaccinia Ankara Vectored Vaccines Expressing ME-TRAP.

scientific article published on 15 June 2016

Safety and Immunogenicity of Adenovirus and Poxvirus Vectored Vaccines against a Mycobacterium Avium Complex Subspecies

scientific article published on 16 March 2021

Safety and Immunogenicity of a Novel Recombinant Simian Adenovirus ChAdOx2 as a Vectored Vaccine

scientific article published on 15 May 2019

Safety and Immunogenicity of the Heterosubtypic Influenza A Vaccine MVA-NP+M1 Manufactured on the AGE1.CR.pIX Avian Cell Line

scientific article published on 22 March 2019

Safety and efficacy of ChAdOx1 RVF vaccine against Rift Valley fever in pregnant sheep and goats

scientific article published on 18 October 2019

Safety and efficacy of novel malaria vaccine regimens of RTS,S/AS01B alone, or with concomitant ChAd63-MVA-vectored vaccines expressing ME-TRAP

scientific article published on 09 October 2018

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

scientific article published on 08 December 2020

Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial

scientific article published on 18 November 2020

Safety and immunogenicity of DNA/modified vaccinia virus ankara malaria vaccination in African adults

scientific article

Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial

scientific article published on 20 April 2020

Safety and immunogenicity of a heterologous prime-boost Ebola virus vaccine regimen - ChAd3-EBO-Z followed by MVA-EBO-Z in healthy adults in the UK and Senegal

scientific article published on 01 April 2019

Safety and immunogenicity of an FP9-vectored candidate tuberculosis vaccine (FP85A), alone and with candidate vaccine MVA85A in BCG-vaccinated healthy adults: a phase I clinical trial.

scientific article published on 10 November 2012

Safety and immunogenicity of heterologous prime-boost immunisation with Plasmodium falciparum malaria candidate vaccines, ChAd63 ME-TRAP and MVA ME-TRAP, in healthy Gambian and Kenyan adults

scientific article

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

scientific article published on 20 July 2020

Safety and immunogenicity of the malaria candidate vaccines FP9 CS and MVA CS in adult Gambian men.

scientific article published on 28 June 2006

Safety of DNA and modified vaccinia virus Ankara vaccines against liver-stage P. falciparum malaria in non-immune volunteers

scientific article published in May 2003

Safety of recombinant fowlpox strain FP9 and modified vaccinia virus Ankara vaccines against liver-stage P. falciparum malaria in non-immune volunteers

scientific article published on 2 February 2006

Safety profile of the viral vectors of attenuated fowlpox strain FP9 and modified vaccinia virus Ankara recombinant for either of 2 preerythrocytic malaria antigens, ME-TRAP or the circumsporozoite protein, in children and adults in Kenya

scientific article published on 14 March 2006

Safety, immunogenicity and efficacy of a pre-erythrocytic malaria candidate vaccine, ICC-1132 formulated in Seppic ISA 720.

scientific article published on January 2005

Safety, immunogenicity, and efficacy of prime-boost immunization with recombinant poxvirus FP9 and modified vaccinia virus Ankara encoding the full-length Plasmodium falciparum circumsporozoite protein

scientific article published on May 2006

Simian adenovirus vector production for early-phase clinical trials: A simple method applicable to multiple serotypes and using entirely disposable product-contact components

scientific article published on 30 April 2019

Simian adenoviruses as vaccine vectors.

scientific article published on 15 September 2016

Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials

scientific article published in February 2021

Single-dose immunogenicity and protective efficacy of simian adenoviral vectors against Plasmodium berghei

scientific article published on March 2008

Single-dose protection against Plasmodium berghei by a simian adenovirus vector using a human cytomegalovirus promoter containing intron A

scientific article published on 6 February 2008

Social Media in Educational Practice: Faculty Present and Future Use of Social Media in Teaching

scholarly article published 2017

Statistical modelling of data showing pandemic H1N1 2009 swine influenza a virus infection kinetics in vaccinated pigs

scientific article published on 28 September 2019

Studies on lipid accumulaltion and genetics of Rhodosporidium toruloide

Substantially reduced pre-patent parasite multiplication rates are associated with naturally acquired immunity to Plasmodium falciparum

scientific article published on May 2011

Synergistic DNA-MVA prime-boost vaccination regimes for malaria and tuberculosis

scientific article

T-cell responses in children to internal influenza antigens, 1 year after immunization with pandemic H1N1 influenza vaccine, and response to revaccination with seasonal trivalent-inactivated influenza vaccine

scientific article

Tackling human and animal health threats through innovative vaccinology in Africa

scientific article published on 02 July 2018

Tailoring subunit vaccine immunogenicity: maximizing antibody and T cell responses by using combinations of adenovirus, poxvirus and protein-adjuvant vaccines against Plasmodium falciparum MSP1.

scientific article

The SPf66 Malaria Vaccine: Where Do We Go From Here?

scientific article published in December 1998

The induction and persistence of T cell IFN-gamma responses after vaccination or natural exposure is suppressed by Plasmodium falciparum

scientific article published on September 2007

The relative magnitude of transgene-specific adaptive immune responses induced by human and chimpanzee adenovirus vectors differs between laboratory animals and a target species

scientific article

The requirement for potent adjuvants to enhance the immunogenicity and protective efficacy of protein vaccines can be overcome by prior immunization with a recombinant adenovirus

scientific article

The teaching practices inventory: a new tool for characterizing college and university teaching in mathematics and science

scientific article

The utility of Plasmodium berghei as a rodent model for anti-merozoite malaria vaccine assessment

scientific article published on January 2013

Theileria parva candidate vaccine antigens recognized by immune bovine cytotoxic T lymphocytes

scholarly article

Thick blood film examination for Plasmodium falciparum malaria has reduced sensitivity and underestimates parasite density

scientific article

Towards a universal vaccine for avian influenza: protective efficacy of modified Vaccinia virus Ankara and Adenovirus vaccines expressing conserved influenza antigens in chickens challenged with low pathogenic avian influenza virus

scientific article

Transcriptomic profiling facilitates classification of response to influenza challenge

scientific article

Transgene optimization, immunogenicity and in vitro efficacy of viral vectored vaccines expressing two alleles of Plasmodium falciparum AMA1

scientific article (publication date: 2011)

Translating the immunogenicity of prime-boost immunization with ChAd63 and MVA ME-TRAP from malaria naive to malaria-endemic populations

scientific article

Ty virus-like particles, DNA vaccines and Modified Vaccinia Virus Ankara; comparisons and combinations

scientific article published in March 1999

T‐cell‐inducing vaccines – what’s the future

scientific article published on January 1, 2012

UK vaccines network: Mapping priority pathogens of epidemic potential and vaccine pipeline developments

scientific article published on 12 September 2019

Upregulation of TGF-beta, FOXP3, and CD4+CD25+ regulatory T cells correlates with more rapid parasite growth in human malaria infection

scientific article published on September 2005

Uses and Gratifications factors for social media use in teaching: Instructors’ perspectives

scholarly article by Anatoliy Gruzd et al published 9 August 2016 in New Media & Society

Utilizing poxviral vectored vaccines for antibody induction—Progress and prospects

scientific article published on 05 June 2013

Vaccination With Viral Vectors Expressing Chimeric Hemagglutinin, NP and M1 Antigens Protects Ferrets Against Influenza Virus Challenge

scientific article published on 21 August 2019

Vaccination with viral vectors expressing NP, M1 and chimeric hemagglutinin induces broad protection against influenza virus challenge in mice

scientific article published on 06 August 2019

Vaccine platforms for the prevention of Lassa fever

scientific article published on 23 April 2019

Vaccine-mediated protection of pigs against infection with pandemic H1N1 2009 swine influenza A virus requires a close antigenic match between the vaccine antigen and challenge virus

scientific article published on 23 March 2019

Vaccines That Reduce Viral Shedding Do Not Prevent Transmission of H1N1 Pandemic 2009 Swine Influenza a Virus Infection to Unvaccinated Pigs

scientific article published on 02 December 2020

Vaccines based on the replication-deficient simian adenoviral vector ChAdOx1: Standardized template with key considerations for a risk/benefit assessment

scientific article published on 14 June 2022

Viral Booster Vaccines Improve Mycobacterium bovis BCG-Induced Protection against Bovine Tuberculosis

scholarly article by H. Martin Vordermeier et al published 19 April 2011 in Infection and Immunity

Viral booster vaccines improve Mycobacterium bovis BCG-induced protection against bovine tuberculosis

scientific article published on June 2009

Viral vectored transmission blocking vaccines against Plasmodium falciparum.

scientific article

Virus-like particles as vaccine adjuvants

scientific article published on October 1, 2001

Wanted: UX Specialist with Reference Preparation or Reference Classes Assist Students in Preparing for UX Careers

What Lies Beneath: Antibody Dependent Natural Killer Cell Activation by Antibodies to Internal Influenza Virus Proteins

scientific article published on 28 April 2016